Asit Parikh

9.2k citations
41 papers · 6.9k indexed · 4 hit papers · h-index 23
Topics
Inflammatory Bowel Disease (24 papers)Microscopic Colitis (19 papers)Pharmacogenetics and Drug Metabolism (8 papers)

In The Last Decade

Asit Parikh

41 papers receiving 6.8k citations

Hit Papers

Vedolizumab as Induction and Maintenance Therapy for Ulce...2013202620172021201320132016201450010001.5k2.0k

Peers

Asit Parikh
Comparison fields: 5 of 116
  • Genetics 5.2k
  • Epidemiology 4.0k
  • Immunology 2.2k
  • Surgery 1.5k
  • Molecular Biology 648
Replace Serap Sankoh with:
Serap Sankoh United States
Kiron M. Das United States
Cord Langner Austria
Mary P. Bronner United States
Hendrik M. van Dullemen Netherlands
Jan H. Kleibeuker Netherlands
B C Morson United States
Sonny L. Johansson United States
Antonia R. Sepulveda United States
Margaret F. Bassendine United Kingdom
Asit Parikh relative to Serap Sankoh United States Serap Sankoh's profile →
Citations per field
00.5×1.5×
Serap Sankoh · 1×
Citations per year

Countries citing papers authored by Asit Parikh

Since Specialization
Citations

This map shows the geographic impact of Asit Parikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asit Parikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asit Parikh more than expected).

Fields of papers citing papers by Asit Parikh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asit Parikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asit Parikh. The network helps show where Asit Parikh may publish in the future.

Co-authorship network of co-authors of Asit Parikh

This figure shows the co-authorship network connecting the top 25 collaborators of Asit Parikh. A scholar is included among the top collaborators of Asit Parikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asit Parikh. Asit Parikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 126
3
The safety of vedolizumab for ulcerative colitis and Crohn's diseasebreakdown →
563
4 38
5 43
6 134
7
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failedbreakdown →
531
8 4
9 70
10
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitisbreakdown →
2048
11 64
12
Vedolizumab as Induction and Maintenance Therapy for Crohn's Diseasebreakdown →
2011
13 182
14 227
15 5
16 16
17 51
18 29
19 262
20 28

About Asit Parikh

Asit Parikh is a scholar working on Pharmacology, Genetics and Epidemiology, having authored 41 papers that have together received 6.9k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (24 papers), Microscopic Colitis (19 papers) and Pharmacogenetics and Drug Metabolism (8 papers). The work is most often cited by research in Genetics (5.2k citations), Epidemiology (4.0k citations) and Immunology (2.2k citations). Asit Parikh has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Brian G. Feagan, Irving H. Fox, Catherine Milch, Serap Sankoh, William J. Sandborn, Bruce E. Sands, Jean‐Frédéric Colombel, Paul Rutgeerts, Jing Xu and Tim Wyant. Their work appears in journals such as New England Journal of Medicine, Nature Biotechnology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026